IV data first: Astera Labs' recent month IV is around 85%, historical volatility is about 60%, with a 25-point premium, and IV Percentile is around the 80th. The Put/Call ratio is about 0.55, significantly skewed towards calls.
Open interest is heavily concentrated in the $85-$100 strike price range, with the market pricing in the upside elasticity for the Q1 earnings report (expected EPS YoY +63.6%, revenue YoY +83.5%).
The GEX positive gamma concentration zone is at $80-$90, and the negative gamma acceleration zone is above $100. The implied probability distribution from the options market supports a directional bullish view.
$Tradr 2X Long ALAB Daily ETF(LABX.US) As a 2x leveraged instrument, naked call buying is expensive when IV is high. Consider using LABX as an alternative for short-term directional exposure to control premium costs.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
